Robatumumab (Anti-IGF1R / CD221)

Robatumumab (Anti-IGF1R / CD221) is an antibody targeting human IGF-1R (insulin-like growth factor receptor-1). It shows anti-tumor activity and anti-proliferative activity to cancer cells and can be used in osteosarcoma and Ewing sarcoma research. MW :144.6 KD

• Supplier: Selleck Chemicals
• Product #: A3044
• Sku #: A3044-1mg